The predicted effect of IL32 is not detected in the network ensemble built from data from TNF-α blocker treated subjects, agreeing with experimental data and further suggesting that the treated network ensemble is capturing TNF-α independent mechanisms in RA. Here, TNF is linked to rheumatoid arthritis.